Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · IEX Real-Time Price · USD

2.390

-0.060 (-2.45%)

At close: Jul 19, 2024, 4:00 PM

2.400

+0.010 (0.42%)

Pre-market: Jul 22, 2024, 7:22 AM EDT

Esperion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	229.74	116.33	75.48	78.45	227.55	148.36	Upgrade
Revenue Growth (YoY)	183.74%	54.14%	-3.79%	-65.52%	53.37%	-	Upgrade
Cost of Revenue	41.69	43.27	26.97	14.22	2.39	0	Upgrade
Gross Profit	188.05	73.07	48.51	64.23	225.16	148.36	Upgrade
Selling, General & Admin	154.61	142.52	109.08	184.99	199.62	65.85	Upgrade
Research & Development	68.13	86.11	118.93	105.98	146.94	175.61	Upgrade
Operating Expenses	222.74	228.63	228.01	290.96	346.55	241.47	Upgrade
Operating Income	-34.69	-155.56	-179.5	-226.73	-121.4	-93.1	Upgrade
Interest Expense / Income	58.61	58.98	56.81	46.35	22.67	8.12	Upgrade
Other Expense / Income	-6.8	-5.29	-2.65	-3.98	-0.52	-4.06	Upgrade
Pretax Income	-86.51	-209.25	-233.66	-269.11	-143.55	-97.17	Upgrade
Net Income	-86.51	-209.25	-233.66	-269.11	-143.55	-97.17	Upgrade
Shares Outstanding (Basic)	169	103	66	29	27	27	Upgrade
Shares Outstanding (Diluted)	190	103	66	29	27	27	Upgrade
Shares Change	141.77%	55.26%	129.76%	5.20%	1.42%	1.26%	Upgrade
EPS (Basic)	-0.97	-2.03	-3.52	-9.31	-5.23	-3.59	Upgrade
EPS (Diluted)	-0.99	-2.03	-3.52	-9.31	-5.23	-3.59	Upgrade
Free Cash Flow	-27.38	-135.49	-174.83	-263.81	-86.05	-71.29	Upgrade
Free Cash Flow Per Share	-0.16	-1.31	-2.63	-9.13	-3.13	-2.63	Upgrade
Gross Margin	81.85%	62.81%	64.27%	81.88%	98.95%	100.00%	Upgrade
Operating Margin	-15.10%	-133.72%	-237.83%	-289.02%	-53.35%	-62.75%	Upgrade
Profit Margin	-37.65%	-179.87%	-309.58%	-343.04%	-63.09%	-65.49%	Upgrade
Free Cash Flow Margin	-11.92%	-116.46%	-231.64%	-336.29%	-37.81%	-48.05%	Upgrade
EBITDA	-27.81	-150.11	-176.35	-222.14	-120.33	-88.73	Upgrade
EBITDA Margin	-12.11%	-129.03%	-233.65%	-283.18%	-52.88%	-59.80%	Upgrade
Depreciation & Amortization	0.08	0.16	0.5	0.61	0.55	0.32	Upgrade
EBIT	-27.89	-150.27	-176.85	-222.76	-120.88	-89.05	Upgrade
EBIT Margin	-12.14%	-129.17%	-234.31%	-283.96%	-53.12%	-60.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).